35 results
8-K
EX-10.1
sta2pci2u 5j
5 Sep 23
Xilio Therapeutics Announces Promotion of Katarina Luptakova, M.D., to Chief Medical Officer and Scott Coleman, Ph.D., to Chief Development Officer
8:35am
8-K
mk3qzx1czr3o7ha9 kr
14 Aug 23
Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2023 Financial Results
7:40am
8-K
EX-10.1
e4t4hxk
3 Aug 23
Departure of Directors or Certain Officers
4:15pm
8-K
xympp d1umu2et8gfdf
25 May 23
Regulation FD Disclosure
5:05pm
8-K
6kn7wha9k27svv9d
9 Nov 22
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2022 Financial Results
7:45am
8-K
EX-10.1
9akfjd6ro5ys9anls
16 Jun 22
Departure of Directors or Certain Officers
7:45am
8-K
24rys1p
12 May 22
Xilio Therapeutics Reports Pipeline and Business Highlights and First Quarter 2022 Financial Results
7:36am
DEF 14A
58kq3dbdu89pfab4p
26 Apr 22
Definitive proxy
4:05pm
10-K
j49ma3iupiv4
1 Mar 22
Annual report
4:07pm